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Abstract
Objectives:  Postoperative  cognitive  dysfunction  refers  to  the  problems  associated  with  thought
and memory  that  are  often  experienced  after  major  surgery.  The  aim  of  this  study  is  to  evaluate
the effects  of  intraperitoneally  administered  memantine  on  recovery,  cognitive  functions,  and
pain after  propofol  anesthesia.
Methods:  The  study  was  conducted  in  Gazi  University  Animal  Research  Laboratory,  Ankara,
Turkey in  January  2012.  Twenty-four  adult  female  Wistar  Albino  rats  weighing  170--270  g  were
educated for  300  s  in  the  radial  arm  maze  (RAM)  over  three  days.  Group  P  was  administered
150 mg  kg−1 of  intraperitoneal  (IP)  propofol;  Group  M  was  given  1  mg  kg−1 of  IP  memantine;
and Group  MP  was  given  1  mg  kg−1 of  IP  memantine  before  being  administered  150  mg  kg−1
of  IP  propofol.  The  control  group  received  only  IP  saline.  RAM  and  hot  plate  values  were
obtained after  recovery  from  the  groups  that  received  propofol  anesthesia  and  30  min  after
the administration  of  drugs  in  other  two  groups.
Results:  The  duration  of  recovery  for  Group  MP  was  signiﬁcantly  shorter  than  Group  P
(p <  0.001),  and  the  number  of  entries  and  exits  in  the  RAM  by  Group  MP  was  signiﬁcantly
higher during  the  ﬁrst  hour  when  compared  to  Group  P  (p  <  0.0001).  Hot  plate  values,  on  the
other hand,  were  found  to  be  signiﬁcantly  increased  in  all  groups  when  compared  to  the  control
values, aside  from  Group  C  (p  <  0.0001).
Conclusion:  In  this  study,  memantine  provided  shorter  recovery  times,  better  cognitive  func-
tions, and  reduced  postoperative  pain.  From  this  study,  we  ﬁnd  that  memantine  has  beneﬁcial
effects on  recovery,  cognitive  functions,  and  pain  after  propofol  anesthesia.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).∗ Corresponding author.
E-mails: marslan36@yahoo.com, mustarslan@gmail.com (M. Arslan).
http://dx.doi.org/10.1016/j.bjane.2015.03.002
0104-0014/© 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Efeitos  da  memantina  sobre  a  recuperac¸ão,  func¸ões cognitivas  e  dor  após  a  anestesia
com  propofol
Resumo
Objetivos:  A  disfunc¸ão  cognitiva  no  pós-operatório  refere-se  a  problemas  associados  ao  pensa-
mento e  à  memória  que  são  frequentemente  manifestados  após  uma  cirurgia  de  grande  porte.  O
objetivo  deste  estudo  foi  avaliar  os  efeitos  da  memantina  administrada  por  via  intraperitoneal
sobrea recuperac¸ão,  func¸ões  cognitivas  e  dor  após  a  anestesia  com  propofol.
Métodos:  O  estudo  foi  realizado  no  Laboratório  de  Pesquisa  com  Animais  da  Universidade  de
Gazi, Ankara,  Turquia,  em  janeiro  de  2012.  Vinte  e  quatro  ratos  albinos  do  sexo  feminino,  adul-
tos, da  linhagem  Wistar,  pesando  170-270  g,  foram  treinadosdurante  300  segundos  no  labirinto
radial de  oito  brac¸os  (LRB)  durante  três  dias.  O  Grupo  P  recebeu  150  mg/kg−1 de  propofol  por
via intraperitoneal  (IP);  o  Grupo  H  recebeu  1  mg/kg−1 de  memantina  IP  e  o  Grupo  MP  recebeu
1 mg/kg−1 de  memantina  IP  antes  daadministrac¸ão  de  150  mg/kg−1 de  propofolPI.  O  grupo
controle  recebeu  apenas  soluc¸ão  salina  IP.  Os  valores  doLRB  e  da  placa  quente  foram  obtidos
após a  recuperac¸ão  dos  grupos  que  receberam  propofol  e  30  minutos  após  a  administrac¸ão  dos
fármacos nos  outros  dois  grupos.
Resultados:  O  tempo  de  recuperac¸ão  do  Grupo  MP  foi  signiﬁcativamente  menor  que  o  do  Grupo
P (p  <  0,001),  eo  número  de  entradas  e  saídas  do  LRBdo  Grupo  MP  foi  signiﬁcativamente  maior
durante a  primeira  hora,em  comparac¸ão  com  o  Grupo  P  (p  <  0,0001).  Os  valores  da  placa  quente,
por outro  lado,  foram  signiﬁcativamente  maiores  em  todos  os  grupos,  em  comparac¸ão  com  os
valores dogrupo  controle,  exceto  pelo  Grupo  C  (p  <  0,0001).
Conclusão:  No  presente  estudo,  memantina  proporcionou  tempos  mais  curtos  de  recuperac¸ão,
func¸ões cognitivas  melhores  e  reduziu  a  dor  no  pós-operatório.  A  partir  deste  estudo,  desco-
brimos que  a  memantina  tem  efeitos  benéﬁcos  sobre  a  recuperac¸ão,  func¸ões  cognitivas  e  dor
após anestesia  com  propofol.
©  2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
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ostoperative  cognitive  dysfunction  (POCD)  refers  to  dis-
rders  affecting  attention,  consciousness,  orientation,
erception,  judgment,  and  insight  that  develop  during  the
ostoperative  period.  Although  the  etiology  of  POCD  has  yet
o  be  adequately  explained,  many  factors  have  been  found
o  be  responsible.  Most  recently,  disequilibrium  in  the  neu-
otransmitter  systems  during  the  preoperative  period,  such
s  acetylcholine,  serotonin,  glutamate,  and  aspartate,  has
een  one  of  the  most  commonly  blamed  factors.1--3
The  effects  of  the  nicotinic  system  on  learning,  mem-
ry,  and  cognition  have  been  shown  in  studies  of  both
umans  and  animals.4 This  directly  inﬂuences  attention
hile  also  affecting  learning  and  memory  by  facilitating
cetylcholine,  glutamate,  dopamine,  noradrenaline,  sero-
onin,  and  gamma-aminobutyric  acid  (GABA)  releases  from
he  presynaptic  nicotinic  acetylcholine  receptors  (nAChRs).4
Propofol  is  a  frequently  used  hypnotic  agent  that  works
y  potentializing  the  chloride  ﬂow  of  GABA  by  connect-
ng  to  the  -subunit  in  the  GABA  receptor.  The  alpha  and
amma  (2)  subunits  also  seem  to  contribute  to  the  mod-
lation  of  the  effect  of  propofol  on  the  GABA  receptor.  As
 result  of  this  effect  on  the  GABAA receptors  in  the  hip-
ocampus,  propofol  inhibits  ACh  release  in  the  hippocampus
nd  prefrontal  cortex.  This  seems  to  be  signiﬁcant  in  the
edative  effects  of  propofol.  Propofol  diffuses  inhibition  on
-methyl-d-aspartate  (NMDA)  which  is  a  subtype  of  gluta-
ate  receptor,  by  modulating  the  gate  mechanism  in  the
odium  channels  and  thus  contributing  to  the  central  nervous
T
tenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
ystem  (CNS)  effects.  Propofol  is  also  effective  on  the  GABAA
nd  glycine  receptors  on  the  dorsal  horn  of  the  spinal  cord,
nd  modulation  of  these  receptors  is  known  to  result  in  cog-
itive  dysfunction.  Propofol  is  reported  to  inhibit  cognitive
unctions  for  up  to  6  h.5,6
Memantine  is  a  non-competitive  receptor  antagonist
ith  a  low  afﬁnity  that  inhibits  the  pathological  activa-
ion  of  NMDA  receptors  without  changing  their  physiological
unctions.7 Memantine  has  demonstrated  an  ability  to
everse  the  changes  that  develop  in  the  synaptic  plastic-
ty  of  animal  models  after  its  use  was  suggested  for  various
eurological  disorders.8 The  use  of  memantine  has  yielded
ositive  results  on  learning,  memory,  pain,  and  neuroprotec-
ive  effects  in  clinical  studies.9 As  a  result,  it  was  sent  to  the
ood  and  Drug  Administration  (FDA)  in  2003  for  approval  for
he  treatment  of  Alzheimer’s  disease.  There  have  also  been
tudies  investigating  the  use  of  memantine  in  the  treatment
f  chronic  pain,10 in  which  it  has  been  shown  to  decrease
iabetic  neuropathy  pain  in  rats.11
In  the  present  study,  the  effects  of  memantine  adminis-
ration  prior  to  propofol  anesthesia  on  recovery,  cognitive
unctions,  and  acute  pain  are  evaluated.
aterials and methodshis  study  was  conducted  in  the  animal  research  labora-
ory  of  Gazi  University  in  January  2012  with  the  consent
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of  the  Experimental  Animals  Ethics  Committee  of  Gazi  Uni-
versity.  All  of  the  procedures  were  performed  according  to
the  accepted  standards  of  the  Guide  for  the  Care  and  Use  of
Laboratory  Animals.
Twenty-four  adult  female  Wistar  Albino  rats  weighing
170--270  g  were  used.  The  rats  were  kept  in  lightened
and  darkened  mediums  for  alternating  24  h  periods  until
the  beginning  of  the  study  to  allow  them  to  adapt  to
the  medium.  The  subjects  were  left  in  a  light-  and  heat-
standardized  medium  and  fed  with  standard  pellet  feed.
There  was  no  restriction  on  access  to  water;  however,  the
rats  were  deprived  of  food  for  2  h  before  the  study.
All  rats  were  weighed  and  the  results  were  recorded  for
all  groups.  After  being  deprived  of  food  for  2  h  prior  to
the  study,  pellet  food  was  placed  at  the  end  of  each  arm
of  a  radial  arm  maze  (RAM).  The  rats  were  educated  in
the  RAM  for  300  s  over  the  ﬁrst  three  days  of  the  study,
and  the  entry  and  exit  times  of  the  rats  at  the  arms  of
the  RAM  were  recorded.  The  RAM  and  hot  plate  basal  val-
ues  were  measured  for  all  rats  on  the  fourth  day  of  the
study,  after  which  the  rats  were  randomly  allocated  into  four
groups.
Group  C  (Control  group,  n  =  6):  each  rat  was  administered
1  ml  of  0.9%  sodium  chloride  (saline)  intraperitoneally  (IP).
Rats  were  placed  in  the  RAM  30  min  after  the  administration
of  saline  IP,  and  the  entry  and  exit  times  at  the  arms  at
beginning  T0,  1  h  (T1),  and  2  h  (T2),  as  well  as  the  durations
on  the  hot  plate,  were  measured  and  recorded.
Group  M  (Memantine  group,  n  =  6):  1  mg  kg−1 dose
of  memantine  (memantine  hydrochloride,  Sigma--Aldrich
Chemie,  St.  Louis,  MO,  USA)  in  1  ml  saline  was  administered
IP.  Thirty  minutes  after  the  administration  of  memantine,
the  rats  were  placed  in  the  RAM.  The  entry  and  exit  times
at  the  arms  at  T0,  T1,  and  T2,  and  the  durations  on  the  hot
plate,  were  measured  and  recorded.
Group  P  (Propofol  group,  n  =  6):  150  mg  kg−1 dose  of
propofol  1%  (propofol  1%,  Fresenius  Kabi  AB,  Germany)  was
administered  IP  and  the  application  time  was  recorded  in
all  rats.  The  rats  were  left  to  recover,  then  recovery  was
evaluated  with  a  tail  pinch  test  (squeezing  the  tail  3--4  cm
from  the  base  for  30  s  using  ‘‘rubber  dam’’  forceps)12 and
the  time  for  recovery  was  recorded.  The  rats  were  placed  in
the  RAM  after  recovery.  The  ﬁrst  measurement  after  recov-
ery  was  recorded  as  0  (T0)  hour,  after  which  the  ﬁrst  hour
(T1)  and  second  hour  (T2)  measurements  were  obtained  and
recorded.
Group  MP  (Memantine  +  propofol  group,  n  =  6):  1  mg  kg−1
dose  of  memantine  was  applied  IP  and  30  minutes  later
150  mg  kg−1 of  propofol  was  injected  IP.  Propofol  applica-
tion  time  was  recorded  in  all  rats.  The  rats  were  left  to
recover,  recovery  was  evaluated  with  a  tail  pinch  test,  and
the  time  for  recovery  was  recorded.  The  rats  were  placed  in
the  RAM  after  recovery.  The  ﬁrst  measurement  after  recov-
ery  was  recorded  as  0  (T0)  hour,  after  which  the  ﬁrst  hour
(T1)  and  second  hour  (T2)  measurements  were  obtained  and
recorded.
The  radial  arm  mazeThe  radial  arm  maze  is  comprised  of  a  Plexiglass  central
platform  measuring  30  cm  with  eight  equidistant  arms  radi-
ating  outwards  (for  example,  80  cm  ×  12.5  cm)  with  a  height
w
w
f 487
f  66  cm.  The  areas  around  the  maze  are  visible  to  permit
he  orientation  of  rats,  and  rats  move  using  those  tips.  For
his  study,  the  RAM  was  placed  on  a  tabletop  90  cm  from  the
oor.
ot  plate  test  for  acute  pain  evaluation
he  aluminum  hot  plate  surface  was  heated  up  to  55 ◦C.
lass  cylinders  were  used  to  ensure  that  the  rats  remained
n  the  heated  region  while  not  limiting  capacity  for  move-
ent.  Movements  such  as  foot  raising,  jumping,  licking,  and
alking  backwards  were  all  accepted  as  positive,  and  the
imes  from  ﬁrst  placement  until  the  ﬁrst  positive  move-
ent  were  recorded.  The  test  was  terminated  after  25  s  to
revent  tissue  damage.
tatistical analysis
 statistical  evaluation  was  performed  using  the  SPSS  12.0
omputer  program  utilizing  the  following  tests.  Statisti-
al  analysis  data  was  presented  as  the  mean  ±  standard
eviation  (minimum--maximum);  p  < 0.05  was  accepted  as
igniﬁcant  in  all  statistical  analyses;  and  p  <  0.033  (0.1/3)
alue  was  accepted  as  signiﬁcant  in  evaluations  of  Bonfer-
oni  corrections.  A  Kolmogorov--Smirnov  test  was  performed
or  the  measurable  parameters  to  identify  normal  or  abnor-
al  distributions.
In  independent  groups,  the  differences  between  the
roups  were  tested  using  a  Kruskal--Wallis  test  and  a
ann--Whitney  U  test,  with  a  Bonferroni  correction  used  to
etect  the  groups  that  generated  differences  when  any  were
dentiﬁed.
esults
he  body  weights  of  the  subjects  (g)  were  similar  in  all
roups.
The  time  period  in  the  tail  pinch  test  was  signiﬁcantly
horter  in  Group  MP  when  compared  to  Group  P  (Table  1).
The  basal  measurements  of  the  hot  plate  were  similar  in
ll  groups  (Table  1).  The  hot  plate  values  were  found  to  be
igniﬁcantly  increased  in  all  measured  time  periods  in  groups
,  P,  and  MP  when  compared  to  Group  C.
The  RAM  values  were  found  to  be  similar  between  the
roups  on  the  days  before  the  administration  of  anesthesia
Table  2).
The  entry  and  exit  times  at  hours  T0, T1, and  T2
ere  found  to  be  signiﬁcantly  decreased  in  Group  P  when
ompared  to  Group  C  (p  <  0.0001,  p  <  0.0001,  p  =  0.029,
espectively).  Only  in  Group  MP  were  the  entry  and  exit
imes  at  T0 signiﬁcantly  decreased  when  compared  to  Group
 (p  =  0.001).
The  entry  and  exit  times  at  T0 and  T1 were  found  to  be  sig-
iﬁcantly  decreased  in  Group  P  when  compared  to  Group  M
p  <  0.0001,  p  < 0.0001,  respectively).  Only  in  Group  MP  were
he  entry  and  exit  times  at  T0 signiﬁcantly  decreased  when
ompared  to  Group  M  (p  <  0.0001),  and  only  in  Group  MP
ere  the  entry  and  exit  times  at  T1 signiﬁcantly  decreased
hen  compared  to  Group  P  (p  =  0.030).
The  results  for  the  evaluation  of  each  group  are  as
ollows:
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Table  1  Tail  pinch  and  hot  plate  data  for  all  groups  [mean  ±  SD  (minimum--maximum)].
Group  C
(n  =  6)
Group  M
(n  =  6)
Group  P
(n  =  6)
Group  MP
(n =  6)
p
Tail  pinch  (min)  --  --  229.50  ±  25.11
(215--278)
152.20  ±  25.13b
(125--175)
0.001
Hot plate  basal  (s) 4.82  ±  2.03
(2.3--8.2)
5.50  ±  2.63
(3.1--9.9)
6.98  ±  1.82
(4.6--9)
6.08  ±  2.03
(3.6--9.5)
0.374
Hot plate  T0 (s)  6.03  ±  2.23
(3.3--8.6)
17.94  ±  8.26a,c
(7.7--25)
22.98  ±  4.94a,c
(12.9--25)
23.40  ±  3.58a,c
(17.0--25)
<0.0001
Hot plate  T1 (s)  5.83  ±  1.99
(3.3--7.9)
23.98  ±  2.95a,c
(18--25)
17.42  ±  7.66a,c
(5.5--25)
20.00  ±  7.87a,c
(7--25)
<0.0001
Hot plate  T2 (s)  5.73  ±  1.91
(3.3--7.9)
24.17  ±  2.04a,c
(20--25)
18.67  ±  6.65a,c
(8--25)
17.30  ±  8.95a,c
(6--25)
<0.0001
a p < 0.05 (compared to Group C).
b p < 0.05 (compared to Group P).
c p < 0.05 (compared to hot plate basal measurement).
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c.  Entry  and  exit  times  were  found  to  be  similar  between
the  ﬁrst  day  measurements  and  other  measurements  in
Group  C  and  Group  M.
.  In  Group  P,  the  entry  and  exit  times  at  T0 and  T1 were  sig-
niﬁcantly  decreased  (p  =  0.011,  p  =  0.011,  respectively).
.  In  Group  PM,  the  entry  and  exit  times  were  signiﬁcantly
reduced  only  at  T0 (p  =  0.006)  (Table  2).
iscussion
his  study  evaluating  the  effects  of  memantine  on  postop-
rative  recovery  and  pain  in  rats  has  revealed  a  decrease  in
ecovery  time  and  in  the  recovery  of  cognitive  functions.  It
as  also  found  to  be  effective  in  the  management  of  acute
ain.
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Table  2  Data  of  entry  and  exits  of  the  radial  arm  maze  in  all  gro
Group  C
(n  =  6)
Group  M
(n  =  6)
Day  1  (entry--exit)  (s)  7.50  ±  3.21
(2--11)
6.33  ±  1.63
(4--8)
Day 2  (entry--exit)  (s)  5.50  ±  3.27
(1--11)
6.17  ±  3.13
(3--11)
Day 3  (entry--exit)  (s)  5.67  ±  2.16
(2--8)
4.00  ±  1.41
(2--6)
Time T0 (entry--exit)  (s)  6.00  ±  2.97
(3--11)
6.83  ±  2.48
(3--10)
Time T1 (entry--exit)  (s)  5.67  ±  2.33
(3--9)
5.50  ±  1.38
(3--7)
Time T2 (entry--exit)  (s)  5.50  ±  2.07
(3--8)
4.17  ±  1.72
(2--7)
a p < 0.05 (compared with Group C).
b p < 0.05 (compared with Group M).
c p < 0.05 (compared with Group P).
d p < 0.05 (compared with 1st day measurement).A  standardization  of  perioperative  and  postoperative
actors  is  difﬁcult  in  clinical  studies  associated  with  postop-
rative  cognitive  functions  due  to  the  different  parameters
nvolved,  including  the  type  of  surgery,  the  distribution  of
ge,  the  interaction  of  anesthesia,  the  presence  of  bleeding
esulting  from  surgery,  and  the  possibility  of  infection.  While
he  effects  of  anesthesia  on  cognitive  functions  have  been
emonstrated  in  previous  experimental  studies,13 this  study
as  adopted  the  RAM  method,  in  which  only  the  parameter
f  the  anesthetic  agent  is  changed  and  all  other  factors  are
tandardized.
RAM  is  a  frequently  used  method  for  the  evaluation  of
ognitive  functions  in  experimental  animal  models.13 Cul-
ey  et  al.,13 used  a  RAM  with  12  arms  in  a  study  evaluating
he  effects  of  nitrous  oxide  on  learning  disorders  in  rats.
s  in  the  present  study,  they  also  left  the  rats  for  10  min
or  three  consecutive  days  on  the  RAM  to  measure  levels
ups  [mean  ±  SD  (minimum--maximum)].
Group  P
(n  =  6)
Group  MP
(n =  6)
p
7.67  ±  2.58
(5--12)
7.50  ±  4.03
(0--11)
0.858
8.00  ±  4.19
(4--15)
5.83  ±  3.49
(0--10)
0.625
6.00  ±  4.60
(0--11)
6.50  ±  4.76
(0--11)
0.649
0.17  ±  0.40a,b,d
(0--1)
0.00  ±  0.00a,b,d
(0--0)
<0.0001
0.0  ±  0.0a,b,d
(0--0)
2.60  ±  2.07c
(0--5)
<0.0001
2.17  ±  1.83a
(0--5)
2.40  ±  1.52
(0--4)
0.017
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of  adaptation  and  education,  from  which  they  were  able
to  deduce  that  general  anesthesia  reversibly  impaired  the
previously  learned  spatial  memory  in  older  rats.
Postoperative  cognitive  dysfunction  is  attributed  to  the
use  of  both  IV  and  inhaled  anesthetics,  which  are  believed  to
cause  long-term  structural  changes  in  the  CNS  since  they  can
no  longer  be  identiﬁed  in  the  blood  several  days  after  admin-
istration.  Anesthetic  agents  administered  during  surgery
change  the  behavioral  status  of  the  patient  and  affect  brain
activity  in  at  least  two  mechanisms.  The  ﬁrst  of  these
is  described  as  the  dose-dependent  effect  on  the  brain,
and  the  second  is  the  inhibition  of  region-speciﬁc  neuronal
activity,  disruption  of  functional  relations,  and  disruption
of  the  neural  plexus.14 These  component  neurotransmitter-
mediated  ion  channels,  especially  the  GABA,  glutamate,  and
NMDA  channels,  are  modulated  by  many  anesthetic  agents
and  are  diagnosed  as  targets  of  the  anesthetic  agents  and
receptors  in  both  synaptic  and  extra-synaptic  areas.15
An  analysis  of  the  propofol  used  in  this  study  reveals  that
its  sedative  effects  are  related  to  its  potentialization  of
chloride  ﬂow  through  the  connection  to  the  GABAA recep-
tor    subunit  of  the  hippocampus  and  the  prevention  of
ACh  release  from  the  hippocampus  and  prefrontal  cortex.  In
addition,  propofol  encourages  diffuse  inhibition  in  the  NMDA
receptors,  which  are  the  subtypes  of  glutamate  receptors,
by  modulating  the  gate  mechanism  of  the  sodium  channels.5
Modulation  of  these  receptors  is  known  to  produce  POCD;
consequently,  there  are  many  studies  conﬁrming  the  role  of
propofol  in  the  development  of  POCD.  Kunimatsu  et  al.,16
observed  POCD  in  patients  undergoing  oral  surgery  under
propofol  anesthesia.  In  another  study  supporting  this  ﬁnding,
Nishikawa  et  al.,17 identiﬁed  a  higher  postoperative  delir-
ium  score  in  a  group  of  patients  who  had  been  administered
propofol  and  who  had  been  given  an  epidural  anesthesia
in  their  comparison  of  propofol,  sevoﬂurane,  and  epidu-
ral  anesthesia  in  patients  undergoing  laparoscopic  surgery.
Larsen  et  al.,18 conducted  a  study  of  cognitive  functions
and  recovery  after  propofol,  desﬂurane,  and  sevoﬂurane  in
60  patients  with  ASA  I--II;  the  results  of  this  study  showed
that  the  patients  in  the  propofol  group  awoke  and  recovered
faster  than  those  that  had  been  anesthetized  with  desﬂu-
rane  or  sevoﬂurane.  Desﬂurane  and  sevoﬂurane  anesthesia
showed  similar  effects,  although  the  eye-opening  time  was
shorter  among  those  anesthetized  with  desﬂurane.  In  light  of
these  studies,  the  intention  here  has  been  to  carry  out  this
study  using  propofol  anesthesia,  which  is  known  to  cause
POCD  and  which  allows  for  early  recovery  from  anesthesia.
Another  reason  for  choosing  propofol  as  the  anesthetic  agent
was  its  mechanism  affecting  the  diffuse  inhibition  of  NMDA
receptors,  GABAA receptors,  and  ACh  receptors,  and  the
hypothesis  that  these  effects  are  reversed  by  memantine,
which  is  an  NMDA  receptor  antagonist.
A  search  of  previous  studies  garnered  no  data  on  the
effect  of  memantine  on  cognitive  dysfunction  following
recovery  from  propofol  anesthesia.  For  this  reason,  the
intention  has  been  to  evaluate  the  effects  of  memantine
after  recovery  from  propofol  anesthesia  on  cognitive  func-
tions  and  pain  in  a  rat  model  with  a  minimal  variation  in
variables  and  with  a  single  variable  parameter  using  propofol
as  the  anesthetic  agent.
Memantine,  a  NMDA  antagonist,  was  ﬁrst  tested  on  ani-
mal  models  by  Bigamous,  who  demonstrated  improvements
i
i
i
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n  cognitive  functions  and  deﬁcits  in  neuron  plasticity.19
emantine  is  a  NMDA  receptor  antagonist  that  is  a  non-
issociative  anesthetic.  It  features  rapid  channel  opening
inetics  and  is  a  powerful  voltage-dependent  channel
locker  with  a  lesser  afﬁnity  to  the  NMDA  receptor
hannel.20 In  contrast  to  other  NMDA  receptor  antagonists
ith  dissociative  anesthetic  effects,  it  has  different  phar-
acological  properties.  This  unique  property  of  memantine
llows  it  to  activate  pathological  NMDA  receptors,  while  hav-
ng  no  effect  on  the  physiological  NMDA  receptors  that  have
 critical  role  in  memory  and  learning.21
Memantine  was  approved  for  the  treatment  of
lzheimer’s  disease  by  European  medicines  Agency  (EMEA)
n  Europe  in  2002  and  by  the  FDA  in  the  United  States  in
003.8 Since  then,  memantine  has  been  shown  to  improve
erformance  in  studies  of  various  pharmacological  learning
nd  memory  models  and  was  found  to  be  useful  in  patients
ith  Alzheimer’s  disease.22 The  effect  of  memantine  on
ognitive  functions  in  cases  of  neurodegenerative  diseases,
uch  as  Alzheimer’s,  is  studied  using  different  application
ethods  and  in  different  doses.  An  acute  administration  of
emantine  in  a  5  mg  kg−1 dose  had  no  effect  on  behavior
r  motor  functions23;  however,  the  administration  of  a
0  mg  kg−1 dose  resulted  in  hyperlocomotion  and  deterio-
ation  in  a  ‘‘food-motivated  task’’  test.  A  single  dose  of
0  mg  kg−1 of  memantine  causes  ataxia.24,25
When  memantine  was  administered  in  10  mg  kg−1 and
0  mg  kg−1 doses  prior  to  the  learning  period  in  a  pas-
ive  avoidance  test,  it  was  shown  to  deteriorate  learning
ehavior  and  deter  memory.26 These  results  suggest  that
emantine  produces  beneﬁcial  results  in  low  doses  but
as  harmful  effects  on  behavior  in  high  doses.27 In  a
tudy  that  involved  the  administration  of  donazepil  and
imonabant,  which  are  known  to  cause  cognitive  disor-
ers,  learning  behaviors  were  tested  using  RAM.  Memantine
oses  of  0.1  mg  kg−1, 0.3  mg  kg−1,  and  0.56  mg  kg−1 were
ound  to  decrease  errors  in  the  RAM  test;  however,  doses
f  1.0  mg  kg−1, 3.0  mg  kg−1,  and  10  mg  kg−1 were  found  to
ncrease  deﬁcits.28
The  present  study  involved  the  administration  of
 mg  kg−1 IP  doses  of  memantine;  however,  the  effects  of
ther  doses  cannot  be  predicted,  and  a  similar  study  with
ifferent  doses  of  memantine  should  be  performed.
Generally,  recovery  from  anesthesia  is  determined  by  the
ate  at  which  the  anesthetic  agent  concentrations  in  the
rain  tissue  decrease,  and  the  elimination  rate  of  the  drug.29
t  can  be  deduced  from  the  present  study  that  early  recovery
rom  propofol  anesthesia,  which  was  the  case  in  this  study  in
emantine-administered  rats,  is  due  to  the  common  inter-
ction  of  both  agents  on  the  NMDA  receptor  rather  than  to
n  increase  in  the  elimination  rate.  In  a  study  supporting  the
ffect  of  this  interaction  on  the  level  of  anesthesia,  Brosnan
t  al.,30 used  picrotoxin,  which  is  a  GABAA receptor  antag-
nist,  on  rats  that  had  been  anesthetized  with  isoﬂurane
nd  then  administered  an  NMDA  receptor  antagonist,  MK-801
Dizocilpine),  to  the  rats.  When  they  analyzed  the  isoﬂu-
ane  minimum  alveolar  concentration  (MAC)  value  using  a
tandard  tail  clamping  test,  the  picrotoxin  was  found  to
ncrease  isoﬂurane  MAC  while  the  IV  MK-801  decreased
soﬂurane  MAC.  The  authors  concluded  that  NMDA  receptor
nhibition  played  a  major  role  in  anesthetic  immobilization
nd  that  the  use  of  NMDA  antagonists  affected  MAC.  In  a
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tion by memantine in the treatment of Alzheirme’s disease and90  
tudy  by  Kuroda  et  al.,31 on  the  effects  of  the  NMDA  receptor
ntagonist  dizocilpine  on  isoﬂurane  MAC,  the  MK-801  was
ound  to  decrease  isoﬂurane  MAC  due  to  the  receptor  inter-
ction  through  GABA.
This  study  has  also  analyzed  the  effects  of  NMDA  recep-
or  antagonists  on  cognitive  functions.  When  the  cognitive
unctions  were  analyzed  on  the  RAM  conﬁguration  in  1-
our  intervals  after  awakening,  no  searching  movement  was
bserved  in  the  rats  that  had  been  administered  only  propo-
ol;  however,  searching  movements  were  observed  during
he  ﬁrst  hour  in  Group  MP  (p  <  0.0001).  Searching  movements
tarted  in  the  propofol  group  during  the  second  hour,  with
o  noticeable  differences  between  the  groups.  In  a  study
o  evaluate  cognitive  recovery  through  a  series  of  tests  of
ttention  span,  planning,  late  memory,  and  speech,  Sanou
t  al.,6 found  that  cognitive  recovery  from  propofol  took
etween  1  and  3  h  following  general  anesthesia  and  that
ecovery  to  a  pre-anesthetic  state  took  6  h.  Marshall  et  al.,32
n  a  similar  study  of  propofol  and  alfentanil,  found  that  lev-
ls  of  word  memory  were  decreased  for  5  h.  Although  the
ast  study  was  performed  on  humans,  recovery  from  propofol
n  our  study  started  during  the  ﬁrst  hour  in  the  memantine-
dministered  rats  and  during  the  second  hour  in  the  rats  that
ad  not  been  given  memantine.  Measurements  in  this  study
ere  limited  to  2  h  after  recovery  from  anesthesia,  meaning
hat  the  time  needed  to  reach  a  pre-anesthetic  state  was
ot  evaluated.
It  can  be  deduced  from  this  study  that  NMDA  receptors
lay  a  signiﬁcant  role  in  the  formation  of  neuronal  networks
uring  memory,  learning,  and  development  in  the  mam-
alian  brain.  Since  this  takes  place  in  some  physiological
unctions,  such  as  synaptic  plasticity  and  synapsis  forma-
ion,  the  receptors  are  beneﬁcial  in  explaining  POCD.  This
tudy  has  revealed  that  the  administration  of  memantine  is
eneﬁcial  in  the  recovery  of  cognitive  functions  after  anes-
hesia.
Another  subject  of  our  study  was  the  effect  of  meman-
ine  on  acute  pain.  Grande  et  al.33 have  shown  in  a  clinical
tudy  that  memantine  is  effective  in  eliminating  neuro-
athic  pain  in  patients  after  a  metastatic  spinal  tumor
esection.11,33 The  potential  uses  of  memantine  in  the  treat-
ent  of  chronic  and  neuropathic  pain  raised  the  question
f  whether  it  may  also  be  effective  in  the  treatment  of
tress-related  pain.  The  hot  plate  method,  with  a  standard
eat  of  52 ◦C,  was  used  to  administer  acute  pain,  and  the
easured  basal  pain  levels  before  the  administration  of
emantine  were  similar  in  all  groups.  Serial  measurements
t  1-hour  intervals  were  taken,  from  which  it  was  demon-
trated  that  the  duration  of  pain  response  in  the  memantine,
ropofol,  and  memantine  +  propofol-administered  groups
ere  signiﬁcantly  longer  when  compared  to  the  basal
alues  in  each  group  and  when  compared  to  the  con-
rol  group  (p  <  0.0001);  however,  there  was  no  signiﬁcant
ifference  between  the  memantine,  propofol,  and  meman-
ine  +  propofol-administered  groups.  This  clinical  picture
eveals  that  memantine  is  also  effective  in  the  treatment
f  acute  pain.  As  propofol  is  also  known  to  have  some  anal-
esic  properties,5 this  may  explain  the  similarity  between
he  groups.In  the  study  design,  the  rats  were  permitted  to  stay  on
he  hot  plate  for  a  maximum  of  25  s  when  evaluating  the
nalgesic  effects  of  the  drugs,  which  meant  that  it  was
1U.  Emik  et  al.
ot  possible  to  identify  with  any  certainty  whether  propo-
ol  and  memantine  possess  any  additive  analgesic  effects.
o  interpretation  was  possible  since  the  times  of  the  three
roups  were  similar.  As  the  analgesic  effects  were  followed
p  for  only  2  h,  the  effects  of  the  drugs  on  analgesia  times
ould  not  be  evaluated  clearly.  In  a  study  evaluating  the
ffects  of  memantine  on  acute  pain,  Park  et  al.34 demon-
trated  that  memantine,  given  in  an  IP  dose  of  10  mg  kg−1 (10
imes  the  dose  used  in  our  study)  30  min  before  performing
 trigeminocervical  pain  model  with  a  formalin  injection,
esulted  in  a  decrease  in  pain  scores.  In  contrast  to  the
resent  study,  in  a  study  of  rats  by  Zhan  and  Brennan,35
n  which  memantine  was  used  for  postoperative  pain  con-
rol,  plantar  incisions  were  produced  in  rats  and  memantine
as  applied  intrathecally  through  an  intrathecal  catheter
ith  no  beneﬁcial  results.  In  a  comparative  study  to  evalu-
te  the  local  anesthetic  effects  of  memantine,  Chen  et  al.,36
uggested  that  memantine  produced  better  local  analgesic
ffects  when  compared  to  lidocaine  and  that  NMDA  recep-
ors  contributed  to  this  analgesic  effect.
onclusion
ntraperitoneal  memantine  administration  in  rats  before  the
dministration  of  propofol  anesthesia  was  observed  to  facil-
tate  recovery  from  anesthesia  and  to  have  positive  effects
n  cognitive  functions  and  acute  pain.  This  subject  may  ben-
ﬁt  from  further  evaluation  in  future  studies.
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